Answers are grounded in this paper and cite their sources.
A target antigen for cancer immunotherapy, ganglioside GM2, is expressed on the cell surface of several human cancer types. An efficient chemical synthesis can now make available ample amounts of a structurally well-defined synthetic GM2, free of biological contaminants. This greatly facilitates the systematic construction of safe and efficient GM2 cancer vaccines.
No takes yet. Share an insight, caveat, or question.
Castro‐Palomino et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: